http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-3856822-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-653
filingDate 1995-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-3856822-B2
titleOfInvention Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
abstract Described is a process for preparing chiral compounds of the formula <IMAGE> wherein X1 and X2 are independently F or Cl, and Y is Cl, Br or I, comprising reacting a triol of the formula <IMAGE>etone in the presence of a catalyst, then with a halogen selected from Cl2, Br2 or I2, or N-bromosuccinimide or N-iodosuccinimide.
priorityDate 1994-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163497072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466052267
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID301346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426488005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10990007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465065387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10924391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407419058
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID301346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466901636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425422662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467012910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422175661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146955547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141838386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68213181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466170769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425217346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414246111

Total number of triples: 37.